Literature DB >> 18704269

Prospective assessment of activities of daily living using modified Barthel's Index in children and young adults with low-grade gliomas treated with stereotactic conformal radiotherapy.

Rakesh Jalali1, Debnarayan Dutta, Rashmi Kamble, Tejpal Gupta, Anusheel Munshi, Rajiv Sarin, Ketayun Dinshaw.   

Abstract

PURPOSE: To report prospective evaluations of activities of daily living (ADL) in young patients with low-grade gliomas treated with stereotactic conformal radiotherapy (SCRT).
MATERIALS AND METHODS: Between April 2001 and February 2008, 38 children and young adults (age 5-25 years, median 12.5 years) with low-grade gliomas with residual/progressive disease and treated with SCRT were accrued in a prospective protocol. Patients underwent baseline and follow-up ADL assessments by the modified Barthel's battery, which comprises domains of personal hygiene, bathing self, feeding, toilet, stair climbing, dressing, bowel control, bladder control, ambulation, and chair-bed transfer. RESULT: The patient population consisted of 38 patients (male 29, female 9) with a diagnosis of residual or progressive low-grade glioma (pilocytic astrocytoma in 27, fibrillary astrocytoma in 5, ependymoma in 4, and oligodendroglioma and pleomorphic xanthoastrocytoma in 1 each). Three patients were visually handicapped. Mean of total modified Barthel's ADL score (Barthel' Index, BI) at baseline before staring SCRT was 94.5 (standard deviation 14.8, range 45-100). At 2-year and 3-year follow-up, mean BI was 97.1 and 99, respectively. At baseline pre-radiotherapy assessment, patients with impaired visual function and with low performance status (Karnofsky performance score, KPS < 70) had significantly lower BI than those with normal vision (P <or= 0.001) and with good performance status (P = 0.001). On follow-up, maximum improvement in individual BI was seen in the ambulation-related domain in patients with impaired visual function (P = 0.027), low KPS (P = 0.015), and age less than 13 years (P = 0.103). The mean pre-radiotherapy baseline BI of three patients, who eventually developed local recurrence, was only 64 (SD 32.1) as compared with a baseline score of 97.18 seen in patients whose tumor remained controlled at follow-up (P <or= 0.001).
CONCLUSIONS: Young patients with low-grade gliomas after surgical intervention had a lower than normal BI before starting radiotherapy, suggesting a decrease in ADL possibly due to tumor- and surgery-related factors. At 2-year and 3-year follow-up after SCRT, there was no further decrease in mean BI. A significant improvement in BI was seen in visually handicapped patients, patients with poor performance status, and younger patients. Patients who developed tumor recurrence at follow-up had a significantly lower BI at baseline than patients with controlled disease (P <or= 0.001).

Entities:  

Mesh:

Year:  2008        PMID: 18704269     DOI: 10.1007/s11060-008-9666-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  21 in total

Review 1.  Decompressive craniectomy for space-occupying supratentorial infarction: rationale, indications, and outcome.

Authors:  D J Lanzino; G Lanzino
Journal:  Neurosurg Focus       Date:  2000-05-15       Impact factor: 4.047

2.  Evaluation of a nurse-led telephone clinic in the follow-up of patients with malignant glioma.

Authors:  S Sardell; G Sharpe; S Ashley; D Guerrero; M Brada
Journal:  Clin Oncol (R Coll Radiol)       Date:  2000       Impact factor: 4.126

3.  High precision conformal radiotherapy employing conservative margins in childhood benign and low-grade brain tumours.

Authors:  Rakesh Jalali; Ashwini Budrukkar; Rajiv Sarin; Dayananda S Sharma
Journal:  Radiother Oncol       Date:  2005-01       Impact factor: 6.280

4.  Optimization of stereotactically-guided conformal treatment planning of sellar and parasellar tumors, based on normal brain dose volume histograms.

Authors:  J R Perks; R Jalali; V P Cosgrove; E J Adams; S F Shepherd; A P Warrington; M Brada
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

5.  The Barthel Index in assessing the response to palliative radiotherapy in malignant spinal cord compression: a prospective audit.

Authors:  A Makris; I H Kunkler
Journal:  Clin Oncol (R Coll Radiol)       Date:  1995       Impact factor: 4.126

6.  Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response.

Authors:  A Pace; A Vidiri; E Galiè; M Carosi; S Telera; A M Cianciulli; P Canalini; D Giannarelli; B Jandolo; C M Carapella
Journal:  Ann Oncol       Date:  2003-12       Impact factor: 32.976

7.  Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma.

Authors:  Thomas E Merchant; Raymond K Mulhern; Matthew J Krasin; Larry E Kun; Tani Williams; Chenghong Li; Xiaoping Xiong; Raja B Khan; Robert H Lustig; Frederick A Boop; Robert A Sanford
Journal:  J Clin Oncol       Date:  2004-08-01       Impact factor: 44.544

8.  Long-term psychological effects in children treated for intracranial tumors.

Authors:  L Jannoun; H J Bloom
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-04       Impact factor: 7.038

9.  Neurocognitive and functional assessment of patients with brain metastases: a pilot study.

Authors:  Mary A Herman; Ivo Tremont-Lukats; Christina A Meyers; Dianna D Trask; Carrie Froseth; Markus F Renschler; Minesh P Mehta
Journal:  Am J Clin Oncol       Date:  2003-06       Impact factor: 2.339

Review 10.  The international classification of functioning, disability and health and its application to cognitive disorders.

Authors:  Sajay Arthanat; Susan M Nochajski; John Stone
Journal:  Disabil Rehabil       Date:  2004-02-18       Impact factor: 3.033

View more
  12 in total

1.  Symptom cluster analyses based on symptom occurrence and severity ratings among pediatric oncology patients during myelosuppressive chemotherapy.

Authors:  Christina Baggott; Bruce A Cooper; Neyssa Marina; Katherine K Matthay; Christine Miaskowski
Journal:  Cancer Nurs       Date:  2012 Jan-Feb       Impact factor: 2.592

2.  Functional independence, diagnostic groups, hospital stay, and modality of payment in three Croatian seaside inpatient rehabilitation centers.

Authors:  Nada Tomasović Mrčela; Dražen Massari; Tonko Vlak
Journal:  Croat Med J       Date:  2010-12       Impact factor: 1.351

3.  Prospective longitudinal evaluation of emotional and behavioral functioning in pediatric patients with low-grade glioma treated with conformal radiation therapy.

Authors:  Victoria W Willard; Heather M Conklin; Shengjie Wu; Thomas E Merchant
Journal:  J Neurooncol       Date:  2015-01-09       Impact factor: 4.130

Review 4.  Factors influencing quality of life in adult patients with primary brain tumors.

Authors:  Rakesh Jalali; Debnarayan Dutta
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

5.  Adaptive functioning of childhood brain tumor survivors following conformal radiation therapy.

Authors:  Jason M Ashford; Kelli L Netson; Kellie N Clark; Thomas E Merchant; Victor M Santana; Shengjie Wu; Heather M Conklin
Journal:  J Neurooncol       Date:  2014-05       Impact factor: 4.130

Review 6.  Primary anaplastic pleomorphic xanthoastrocytoma with widespread neuroaxis dissemination at diagnosis--a pediatric case report and review of the literature.

Authors:  Toshiyuki Okazaki; Teruyoshi Kageji; Kazuhito Matsuzaki; Hidehisa Horiguchi; Takanori Hirose; Hiroyoshi Watanabe; Toshihiro Ohnishi; Shinji Nagahiro
Journal:  J Neurooncol       Date:  2009-03-27       Impact factor: 4.130

7.  Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice.

Authors:  Ashwini Budrukkar; Rakesh Jalali; Debnarayan Dutta; Rajiv Sarin; Rashmi Devlekar; Sachin Parab; Anagha Kakde
Journal:  J Neurooncol       Date:  2009-06-23       Impact factor: 4.130

8.  Factors influencing activities of daily living using FIM-FAM scoring system before starting adjuvant treatment in patients with brain tumors: results from a prospective study.

Authors:  Debnarayan Dutta; Pushpa Vanere; Tejpal Gupta; Anusheel Munshi; Rakesh Jalali
Journal:  J Neurooncol       Date:  2009-03-03       Impact factor: 4.130

9.  An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy.

Authors:  Christina R Baggott; Marylin Dodd; Christine Kennedy; Neyssa Marina; Katherine K Matthay; Bruce Cooper; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2010-02-16       Impact factor: 3.603

10.  A cross-sectional audit of distress in patients undergoing adjuvant therapy or follow-up in central nervous system malignancies.

Authors:  Vijay M Patil; Mridul Malhotra; Raees Tonse; Jayita Deodhar; Arun Chandrasekharan; Nikhil Pande; Atanu Bhattacharjee; Rakesh Jalali
Journal:  Neurooncol Pract       Date:  2018-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.